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Abstract
Background: Emerging evidence suggests airborne metals may be associated with breast cancer 
risk. However, breast cancer is heterogenous and associations with heavy metals vary by subtype. 
Heavy metals possess both carcinogenic and xenoestrogenic properties which may be related to 
different tumor etiologies. Therefore, we tested for etiologic heterogeneity, using a case-series 
approach, to determine whether associations between residential airborne metal concentrations and 
breast cancer differed by tumor subtype.
Methods: Between 2005–2008, we enrolled incident breast cancer cases into the Breast Cancer 
Care in Chicago study. Tumor estrogen and progesterone receptors status was determined by 
medical record abstraction and confirmed immunohistochemically (N=696; 147 ER/PR-negative). 
The 2002 USEPA’s National Air Toxics Assessment census-tract estimates of metal 
concentrations (antimony, arsenic, beryllium, cadmium, chromium, cobalt, lead, manganese, 
mercury, nickel and selenium) were matched to participants’ residences of the same year. Adjusted 
logistic regression models were used to examine whether the airborne heavy metal associations 
differed by tumor ER/PR status. Principal component analysis was performed to assess 
associations by metal co-exposures.
Results: Comparing the highest and lowest quintiles, higher concentrations of antimony (odds 
ratio[OR]: 1.8, 95% confidence interval[CI]: 0.9, 3.7, P-trend: 0.05), cadmium (OR: 2.3, 95% CI: 
1.2, 4.4, P-trend: 0.04) and cobalt (OR: 2.0, 95% CI: 0.9, 4.4, P-trend: 0.04) were associated with 
Corresponding Author: Jacob K. Kresovich, Epidemiology Branch, National Institute of Environmental Health Sciences, Phone: 
984-287-3731, jacob.kresovich@nih.gov.
1Present address
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflicts of Interests: None declared
IRB Approval: The protocol for this study was approved by the University of Illinois at Chicago Institutional Review Board and all 
study participants gave written, informed consent to participate in the study.
HHS Public Access
Author manuscript
Environ Res. Author manuscript; available in PMC 2020 October 01.
Published in final edited form as:
Environ Res. 2019 October ; 177: 108639. doi:10.1016/j.envres.2019.108639.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
ER/PR-negative breast cancer. Mixture analysis using principal components suggested co-
exposures to multiple airborne heavy metals may drive associations with tumor receptor status.
Conclusions: Among women diagnosed with breast cancer, metallic air pollutants were 
associated with increased odds of developing ER/PR-negative breast cancer.
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1. Introduction
Air pollution affects large populations and may be associated with the development of breast 
cancer [1–7]. Metallic components of air pollution are of interest due to their long half-lives 
and ability to accumulate in breast tissue [8]. Emerging evidence from large, prospective 
cohorts suggest that airborne metals may be related to breast cancer risk. For instance, 
associations have been reported for antimony, arsenic, cadmium, cobalt, mercury and lead 
[9, 10]. These studies suggest airborne metals may affect breast cancer risk in a subtype-
specific manner: Liu et al. (2015) found arsenic and cadmium exposures increased only 
estrogen and progesterone receptor (ER/PR)-negative breast cancer risk; White et al. (2019) 
reported no differential risks for cadmium and lead, but found antimony, cobalt and mercury 
were associated with elevated estrogen receptor (ER)-positive risk.
Findings from experimental studies suggest that heavy metals possess both xenoestrogenic 
and carcinogenic properties, offering a potential hypothesis for the subtype-specific 
associations. Arsenic, beryllium, cadmium, chromium, lead, mercury and nickel have been 
reported to inhibit DNA damage repair proteins by damaging zinc finger motifs and may 
alter DNA damage repair pathways via generation of free radicals [11–15]. These hormone-
independent, biological effects may be more strongly related to development of hormone 
receptor negative breast cancer [16–19]. Other metals, including antimony, arsenic, 
cadmium, cobalt, manganese, and selenium, are reported to mimic estradiol by binding to 
and activating estrogen receptor-alpha [20–22]. Xenoestrogenic exposures may be more 
strongly, but not exclusively, associated with the development of hormone receptor positive 
breast cancer [23, 24]. As some metals possess both carcinogenic and xenoestrogenic 
properties (i.e. arsenic, cadmium), it is possible they may influence breast cancer risk via 
multiple biological pathways.
Based on the broad biological effects of metals, we aimed to test whether exposures to 
airborne metals prior to cancer diagnosis are differentially associated with tumor ER/PR 
status. To accomplish this, we used a case-series design to test for etiologic heterogeneity 
[25, 26]; in instances where modest etiologic heterogeneity exists, the case-series approach 
has been demonstrated to improve statistical power [27]. We hypothesize that metals with 
carcinogenic properties would be associated with ER/PR-negative breast cancer and metals 
with xenoestrogenic properties would be associated with ER/PR-positive breast cancer. 
Based on prior literature, for metals that possessed both, we hypothesized relationships 
would be stronger for ER/PR-negative disease [3].
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2. Materials and Methods
2.1 Study population
Breast Cancer Care in Chicago (BCCC) is a population-based study of recently diagnosed 
breast cancer patients from the Chicagoland area. The study population has been described 
in detail elsewhere [28]. Briefly, women were eligible if diagnosed with a first primary in 
situ or invasive breast cancer between 2005 and 2008; between 30 and 79 years old at 
diagnosis; self-identified as non-Latina (nL) White, nL Black, or Latina; and resided in the 
metropolitan Chicago area at time of diagnosis. Overall, 989 women were enrolled and 
completed an interview on social, demographic, and healthcare-related factors. The protocol 
for this study was approved by the University of Illinois at Chicago Institutional Review 
Board and all study participants gave written informed consent.
2.2 Tumor subtype
Breast tumor ER/PR status was determined via medical record abstraction. Overall, 696 
(70% of the full sample) women had information on tumor ER and PR status. Women were 
classified as ER/PR-positive if either estrogen or progesterone receptors were present and 
classified as ER/PR-negative if both receptor types were absent (double negative). Of the 
696 women, 222 (32%) women consented to retrieval of clinical breast tissue samples where 
ER/PR status was confirmed by immunohistochemical analysis. For the 222 women with 
histologically confirmed subtype, we observed very high concordance (> 99%) with the 
tumor subtype listed in their medical records.
2.3 Residential airborne heavy metal concentrations
To estimate residential, airborne heavy metal concentrations, we combined participant’s 
2002 residential address with census-tract level, ambient air concentration data from 2002 
using the U.S. Environmental Protection Agency’s National Air Toxics Assessment (NATA). 
Use of the 2002 NATA allowed us to examine airborne metal concentrations between three 
to six years prior to breast cancer diagnosis. The process for air toxics concentration 
estimates was as follows: emission data were compiled from countrywide anthropogenic 
sources in the National Emissions Inventory and were prepared for use as model inputs. 
Ambient concentrations of air toxics at the census tract level were estimated using the 
Assessment System for Population Exposure Nationwide (ASPEN) dispersion model for 
area and mobile source emissions and the Human Exposure Model (HEM) dispersion model 
to assess stationary source emissions [29]. Total ambient concentrations, including those of 
11 heavy metals (antimony, arsenic, beryllium, cadmium, chromium, cobalt, lead, 
manganese, mercury, nickel, and selenium) were calculated by combining all exposure 
sources with background concentrations. The NATA estimates reflect Ambient, airborne 
concentrations of heavy metals and do not account for exposures which may occur indoors, 
due to smoking behaviors, or via other routes (i.e., dermal or ingestion).
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2.4 Individual and neighborhood level characteristics
Upon enrollment in the BCCC study, information on age at diagnosis, race/ethnicity, 
education, household income, body mass index (BMI), age at first birth, number of live 
births, and menopausal status were collected via questionnaire.
We constructed established neighborhood-level metrics of socioeconomic affluence and 
disadvantage, defined at the participant’s census tract, using data from the 2000 United 
States Census [28, 30, 31]. Briefly, census tract affluence was defined as the weighted 
contribution of the proportions of families with income of $75,000 or more, adults with 
college education or more, and civilian labor force employed in professional and managerial 
occupations, whereas census tract disadvantage was measured by combining the proportions 
of families with incomes below the poverty line, families receiving public assistance, 
persons unemployed, and female-headed households with children [30, 31]. Both variables 
weighted the relevant input variables equally. We standardized census tract affluence and 
disadvantage so their sum had a mean of zero with a standard deviation of one. Z-scores 
were used to determine low (< −1), intermediate (−1 ≤ z ≤ 1), and high (> 1) levels of 
neighborhood affluence and disadvantage.
2.5 Statistical analysis
We first examined participant characteristics stratified by ER/PR status. For the airborne 
heavy metal concentrations, we explored distributions and examined pairwise Spearman 
correlations (rs). We further examined airborne metal concentrations by race/ethnicity and 
other participant characteristics. Individual heavy metal concentrations were categorized into 
quintiles and modeled using logistic regression to estimate odds ratios and 95% confidence 
intervals with respect to ER/PR-negative breast cancer. P-values for linear trends were 
calculated by including the heavy metal quintiles as ordinal variables. Significant 
associations from case-series studies of etiologic heterogeneity can be interpreted as an 
indication for distinct causal mechanisms for breast cancer subtypes, or a different strength 
of effect via the same mechanism [25].
Based on prior studies in this population, we adjusted our models for predictors of ER/PR 
status [28]. Model covariates included were: age at diagnosis (years); race/ethnicity (nL 
White, nL Black, Latina); BMI (kg/m2; categorized as underweight and normal, < 25; 
overweight, 25–30; obese, 30+); individual and neighborhood-level socioeconomic factors 
(education, income, neighborhood affluence and disadvantage); and reproductive factors 
(age at first birth, number of live births, and menopausal status). To examine the potential 
impact of multiple exposures simultaneously, we performed a principal component analysis 
of the eleven airborne heavy metals. We estimated components if their eigenvalues were 
greater than one and examined metal loading factors into each component. Unlike other 
mixture approaches, principle component analysis is unconstrained and does not rely on 
associations with the outcome to define mixtures [32]. Statistical significance was defined as 
a two-sided P-value ≤ 0.05. Participants were excluded from the present analysis if they 
were missing residence in 2002 (n= 106), breast cancer ER/PR status (n= 187) or any of the 
covariate data (n= 24); thus, the final analytic sample size was 672 (68% of total sample) 
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(Supplemental Figure 1). All analyses were conducted using Stata version 15 (Stata Corp., 
College Station, TX).
3. Results
Table 1 presents the sample population characteristics by tumor hormone receptor status. 
Women diagnosed with ER/PR-positive tumors tended to be older at diagnosis, have fewer 
live births and later ages at first birth. nL Black women were more likely to be diagnosed 
with ER/PR-negative tumors; nL White women were more likely to be diagnosed with 
ER/PR-positive tumors. Obese women and women with lower socioeconomic status (lower 
educational attainment, annual income, and census tract affluence, and higher census tract 
disadvantage) were also more likely to have an ER/PR-negative diagnosis. The odds of 
ER/PR-negative disease were similar for pre- and postmenopausal women. Participants’ age 
at diagnosis, education level, household income, age at first birth and number of live births 
were only weakly correlated with the ambient airborne metal concentrations (−0.2 < rs < 
0.2) (Supplemental Table 1). Conversely, race/ethnicity was related to the airborne metals: 
nL Black women generally resided in census tracts with higher median concentrations of 
antimony, cadmium, lead, and manganese; nL White women resided in census tracts with 
higher median concentrations of arsenic, beryllium, chromium, cobalt, and nickel 
(Supplemental Figure 2). Although 187 women were missing ER/PR status, this missingness 
was not related to any of the airborne metal concentrations (Supplemental Table 2).
The Spearman’s correlations of the heavy metal air concentrations are displayed in Figure 1. 
Generally, the correlations were positive reflecting increasing airborne concentrations of one 
metal was associated with increasing airborne concentrations of others, suggesting co-
exposure is common. For instance, antimony was positively correlated with the other 
estimated air concentrations (rs ranging from 0.15 to 0.58) except for arsenic (rs= −0.05). 
Arsenic showed weak correlations with all other metals. Notably strong correlation 
coefficients were observed for chromium and beryllium (rs= 0.81) and manganese (rs= 0.92), 
as well as beryllium and manganese (rs= 0.71). Distributions of the heavy metal air 
concentrations are presented in Supplemental Table 3. The highest median airborne heavy 
metal concentrations were observed for lead (median= 4.6 ng/m3, interquartile range (IQR)= 
4.2–5.1), manganese (median= 3.5 ng/m3, IQR= 2.7–4.4) and nickel (median= 1.1 ng/m3, 
IQR= 1.0–1.4).
Associations between residential airborne heavy metal concentrations with odds of ER/PR-
negative breast cancer are shown in Table 2. Comparing the highest and lowest quintiles, we 
found elevated odds of ER/PR-negative tumors for antimony (OR= 1.8, 95% CI: 0.9, 3.7), 
cadmium (OR= 2.3, 95% CI: 1.2, 4.4), cobalt (OR= 2.0, 95% CI: 0.9, 4.4) and manganese 
(OR= 2.1, 95% CI: 0.9, 4.8). We observed significant increasing trends for increasing 
concentrations of antimony (P-trend= 0.05), cadmium (P-trend= 0.04), and cobalt (P-trend= 
0.04). Although we did not find evidence of linear trends for airborne lead and manganese 
concentrations with ER/PR status (lead P-trend= 0.16; manganese P-trend= 0.13), 
association point estimates suggested that women residing in census tracts with moderate to 
high concentrations were at increased odds of an ER/PR-negative breast cancer.
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Figure 2 displays the loading factors for the eleven heavy metals into the top four principal 
components. The first component comprised most of the metals equally, with the exceptions 
of arsenic and cadmium; this was the only mixture that showed associations with increasing 
odds of ER/PR-negative breast cancer (Table 3). The second component was mainly 
comprised of lead, mercury and selenium and generally was not associated with breast 
cancer ER/PR status. The third and fourth components were primarily comprised of 
cadmium and arsenic, respectively, and again showed mostly null associations with breast 
cancer receptor status.
4. Discussion
Using a case-series approach to examine the etiologic heterogeneity of breast cancer 
subtypes, we found, after adjustment for individual and neighborhood-level factors, that 
increasing residential airborne concentrations of cadmium, antimony, and cobalt were 
associated with higher odds of ER/PR-negative breast cancer. Suggestive associations with 
ER/PR-negative breast cancer were observed for manganese and lead. Based on studies 
linking airborne concentrations of these metals with breast cancer risk [9, 10], we find 
evidence for distinct causal mechanisms by tumor subtype. For the seven metals that possess 
carcinogenic properties and hypothesized to be associated with ER/PR-negative disease, 
only cadmium was associated with greater odds of ER/PR-negative disease. None of the 
metals previously shown to be xenoestrogenic were associated with greater odds of ER/PR-
positive disease and, contrary to our expectations, both antimony and cobalt were associated 
with higher odds of ER/PR-negative breast cancer. Mixture analysis using a principal 
component approach suggested that the observed associations were likely not driven by a 
single airborne metal, rather co-exposures to multiple metallic airborne components may be 
related to ER/PR-negative breast cancer.
Cadmium is the most studied metal in relation to breast cancer and prior research suggests 
higher airborne exposures may increase breast cancer risk [9, 10]. Among women diagnosed 
with breast cancer, we found increasing airborne concentrations of cadmium were associated 
with higher odds of ER/PR-negative breast cancer. Our findings are supported by Lui et al.’s 
(2015) prospective cohort study that observed higher cadmium concentrations were 
associated with incident ER/PR-negative breast cancer [9]. As studies suggest cadmium has 
both xenoestrogenic and carcinogenic properties, it is possible that cadmium may be 
mechanistically related to both ER/PR-positive and ER/PR-negative breast cancers [13, 22]. 
The stronger association for ER/PR-negative breast cancer identified using the single metal 
model suggested that cadmium’s carcinogenic properties, rather than xenoestrogenic, may 
have a stronger influence on breast cancer development. Interestingly, in our mixture 
analysis, cadmium loaded heavily into the third component, but this component was not 
related to tumor ER/PR status. This may be due to the negative loading of cobalt into the 
same component; cobalt, like cadmium, appeared to increase the odds of ER/PR-negative 
tumors. As these metals loaded into the component with opposing strengths, it is possible 
they canceled out their individual associations with breast cancer subtype.
Based on earlier studies that suggest antimony may be xenoestrogenic and related to breast 
cancer risk [10, 22, 33, 34], we hypothesized that higher airborne concentrations would be 
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associated with ER/PR-positive breast cancer. Contrary to this, we found higher 
concentrations were associated with prevalent ER/PR-negative cancer. Antimony is 
relatively understudied compared to other heavy metals and reported associations in the 
breast cancer literature are mixed. In the only prospective study, White et al. (2019) 
observed moderate, census-tract airborne concentrations were associated with increased ER-
positive risk, while the highest concentrations were associated with lower ER-negative risk 
[10]. In case-control studies using exposure biomarkers, the association is more established: 
compared to cancer-free controls, breast cancer cases are reported to have higher 
concentrations of antimony in both their plasma and hair [33, 34]. Notably, there is limited 
evidence that antimony is genotoxic in mammals and may inhibit DNA damage repair 
enzymes [35–38]. These characteristics may influence ER/PR-negative breast cancer risk 
and potentially support our observation that, among women diagnosed with breast cancer, 
higher airborne concentrations may increase odds of ER/PR-negative disease.
We also identified an association between higher airborne concentrations of cobalt and 
greater odds of ER/PR-negative breast cancer. This observation was discordant with our 
hypothesis that cobalt would be more strongly associated with ER/PR-positive breast cancer 
due to its estrogen-mimicking properties. Although White et al. (2019) observed higher ER-
positive breast cancer risk for women with moderate airborne concentrations, our findings 
suggest that cobalt’s xenoestrogenic effects may not drive associations with breast cancer 
risk. Interestingly, co-exposure to cobalt and lead is associated with both DNA single strand 
breaks and inhibition of DNA damage repair mechanisms, which could increase ER/PR-
negative breast cancer risk [39–41]. Moreover, higher concentrations of airborne cobalt and 
lead are associated with greater mammographic density [42], a potential risk factor for ER-
negative breast cancer [43]. In the present study, cobalt was moderately correlated with lead 
(rs= 0.42), suggesting a possible mixture effect which may potentially explain the observed 
association with ER/PR-negative breast cancer. As most of the airborne metal concentrations 
had similar loading fractions into the first principal component, our mixture analysis 
provided additional support that co-exposures to airborne heavy metals, including cobalt and 
lead, may drive associations with tumor characteristics.
Although this study identified suggestive relationships between residential, airborne heavy 
metal concentrations and odds of ER/PR-negative breast cancer, it is subject to limitations. 
Most importantly, we had to exclude a portion of women due to missing residential history 
(n= 106; 11% of total sample). However, compared to excluded women, those included in 
the final sample had a similar risk of being diagnosed with ER/PR-positive breast cancer 
(79% of women included vs. 76% of women excluded). As inclusion in the final study 
population was not associated with tumor ER/PR status, it is unlikely this missing 
information would bias our association estimates. Similarly, 187 women (20%) were 
missing information on tumor ER/PR status; however, ER/PR status missingness was not 
associated with any of the airborne metal concentrations, thus any bias introduced based on 
selection into the final study population on these criteria is likely to be minimal. The BCCC 
study population was from a single geographic region potentially limiting the 
generalizability and variability in exposures. Nonetheless, 416 unique census tracts were 
represented across the 696 participants, and according to estimates from NATA there was 
considerable variation in airborne heavy metal concentrations within the Chicagoland area. 
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We also relied on 2002 NATA estimates; while these data reflect airborne metal 
concentrations three to six years before diagnosis in our population, breast cancer has a long 
induction and latent period. Thus, future analyses might consider other potential exposure 
windows to identify associations between airborne metals and breast cancer. Although we 
accounted for both individual and neighborhood-level factors related to race and 
socioeconomic status, there exists the potential for residual confounding by other 
environmental stressors. Also, as we used NATA to estimate concentrations of airborne 
metallic components, our analysis does not address other potential sources of metal 
exposures, including from water or diet.
This study builds upon the limited literature linking airborne metallic components with 
breast cancer subtype formation [3, 10]. Although larger studies have investigated the 
relationship between airborne metals and breast cancer risk, this is the first study specifically 
designed to test for etiologic heterogeneity. White et al. (2019) did explore etiologic 
heterogeneity as a secondary analysis, but compared to that study, our participants were far 
more racially and ethnically diverse and, perhaps as a result, lived in census tracts with 
higher airborne metal concentrations. Moreover, the proportion of ER/PR-negative cases in 
our analysis was higher (21%) compared to theirs (14%), giving our investigation improved 
power to detect etiologic heterogeneity. Another strength is this study is only the second to 
address the potential influence of airborne metal mixtures. By applying principal component 
analysis, we used an unsupervised mixture approach based entirely on the correlational 
structure of the airborne metal concentrations [44]. Conversely, the weighted quantile sum 
approach applied in an earlier study was designed to detect the ‘bad actors,’ which may be 
an inappropriate approach with highly correlated components, and when mixtures, rather 
than the individual pollutants, are the true cause of disease development [45]. We found, 
based on the moderate positive correlations between the airborne metal concentrations and 
our mixture analysis, that the observed associations with tumor characteristics are not likely 
driven by a single metal. Finally, although a latency period for breast cancer has not been 
established, we assessed airborne heavy metals between three to six years prior to a 
diagnosis and observed evidence for etiologic heterogeneity, suggesting this time-period 
may reflect an important window of susceptibility for breast tumor subtype formation.
5. Conclusions
Airborne heavy metals have broad carcinogenic and xenoestrogenic properties relevant to 
breast cancer. We found that higher concentrations of cadmium, antimony and cobalt were 
associated with greater odds of ER/PR-negative breast cancer and observed evidence that 
metal mixtures may be important. Additional studies of heavy metal ambient airborne 
concentrations in other geographic regions of the U.S. are required to confirm our findings. 
Moreover, additional epidemiologic studies using biomarkers of chronic inhalation exposure 
and a cohort approach may be required to disentangle the subtype-specific effects of metals 
in relation to breast cancer risk. However, our study demonstrates, on the population-level, 
that airborne metallic components may have greater influence on the development of 
ER/PR-negative, rather than ER/PR-positive, breast cancer.
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Highlights
• Evidence suggests airborne metals are related to subtype-specific breast 
cancer risk
• We tested for etiologic heterogeneity of metallic air pollutants and tumor 
subtype
• Sb, Cd and Co were more strongly associated with ER/PR-negative breast 
cancer
• Mixture analysis suggests that co-exposures to multiple metals is important
• Airborne metals may be more strongly associated with aggressive breast 
cancer subtypes
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Figure 1. 
Spearman correlation matrix for the eleven airborne heavy metal concentrations 
(Abbreviations: Sb, antimony; As, arsenic; Be, beryllium; Cd, cadmium; Cr, chromium; Co, 
cobalt; Pb, lead; Mn, manganese; Hg, mercury; Ni, nickel; Se, selenium).
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Figure 2. 
Loading factors for the eleven airborne heavy metals into the top four principal components.
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Table 1.
Participant characteristics at diagnosis (n= 696)
Tumor receptor status
Characteristic
ER/PR-positive
No. (%)
ER/PR-negative
No. (%)
Total 549 (79) 147(21)
Age, mean yrs. (SD) 56.0(11.3) 53.7(10.6)
Education, mean yrs. (SD) 13.5 (2.9) 12.7 (2.6)
Annual income, mean $/thousand (SD) 65.0 (54.2) 42.0(40.1)
Parity, mean live births (SD) 2.1 (2.0) 2.5(1.8)
Age at first birth, mean yrs. (SD) 27.7 (8.8) 23.8 (8.0)
Race/ethnicity
 nL White 253(88) 35(12)
 nL Black 199 (70) 87 (30)
 Latina 97 (79) 25(21)
Body Mass Index (kg/m2)
 Underweight/Normal (< 24.9) 177(83) 37(17)
 Overweight (25–30) 177(82) 38(18)
 Obese (30+) 192 (73) 72 (27)
 Missing 3 0
Census tract affluence
 Low 28 (72) 11 (28)
 Intermediate 392(77) 118(23)
 High 129 (88) 17(12)
 Missing 0 1
Census tract disadvantage
 Low 102(90) 11(10)
 Intermediate 351 (78) 100(22)
 High 93 (73) 35 (27)
 Missing 0 1
Menopause status
 Premenopausal 106(80) 27 (20)
 Postmenopausal 441 (79) 119(21)
 Missing 2 1
Women with missing continuous covariate information: age, 1 ER/PR-positive; education, 2 ER/PR-positive; income, 14 ER/PR-positive, 3 ER/PR-
negative; age first live birth, 1 ER/PR-positive.
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Table 3.
Odds ratios (OR) and 95% confidence intervals (CIs) for the relationship between residential airborne heavy 
metals mixture quintiles and ER/PR-negative tumor receptor status (n= 672)
Q1 Q2 Q3 Q4 Q5 P-trend
Mixture 1 Ref. 2.0(1.0,4.0) 1.5(0.8,3.1) 2.0(1.0,4.1) 2.3(1.1,4.8) 0.06
Mixture 2 Ref. 1.2(0.6,2.4) 1.9(0.9,3.7) 1.2(0.6,2.5) 1.7(0.9,3.3) 0.19
Mixture 3 Ref. 0.9(0.5,1.6) 0.8(0.4,1.5) 1.0(0.5, 1.8) 1.3(0.7,2.3) 0.42
Mixture 4 Ref. 1.1(0.6,2.1) 1.0(0.5,2.0) 0.7(0.4, 1.4) 1.1 (0.6,2.2) 0.85
Models adjusted for age, race/ethnicity, education, BMI, income, census tract affluence and disadvantage, and reproductive factors.
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